Comment
doi: 10.1016/j.euo.2018.08.002.
Epub 2018 Aug 24.
Re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. N Engl J Med 2018;379:417-27: CARMENA Trial: Is This the End of Cytoreductive Nephrectomy in Patients with Clear-cell Renal Cell Carcinoma?
Affiliations
- PMID: 31200852
- DOI: 10.1016/j.euo.2018.08.002
Item in Clipboard
Comment
Re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. N Engl J Med 2018;379:417-27: CARMENA Trial: Is This the End of Cytoreductive Nephrectomy in Patients with Clear-cell Renal Cell Carcinoma?
Eur Urol Oncol.
2019 May.
No abstract available
Comment on
-
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860937 Clinical Trial.
Similar articles
-
Reply to Michael Staehler, Dena Battle, Axel Bex, Hans Hammers, and Daniel George's Letter to the Editor re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. Eur Urol 2018;74:842-3: Lymphocyte Phenotype and Timing of Radical Nephrectomy in Patients Treated with Immunocheckpoint Inhibitors for Renal Cell Carcinoma.Eur Urol. 2019 Mar;75(3):e64-e66. doi: 10.1016/j.eururo.2018.10.031. Epub 2018 Nov 1. Eur Urol. 2019. PMID: 30391082 No abstract available.
-
Has the Age of Cytoreductive Nephrectomy Come to an End?: Commentary on: Sunitinib Alone or After Nephrectomy in Metastatic Renal-Cell Carcinoma.Urology. 2018 Nov;121:1-2. doi: 10.1016/j.urology.2018.07.007. Epub 2018 Aug 2. Urology. 2018. PMID: 30077538 No abstract available.
-
Cytoreductive nephrectomy: questions remain after CARMENA.Nat Rev Urol. 2018 Sep;15(9):530-532. doi: 10.1038/s41585-018-0064-3. Nat Rev Urol. 2018. PMID: 30054576 No abstract available.
-
The evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma.Curr Opin Urol. 2019 Sep;29(5):507-512. doi: 10.1097/MOU.0000000000000657. Curr Opin Urol. 2019. PMID: 31305275 Review.
-
Position of cytoreductive nephrectomy in the setting of metastatic renal cell carcinoma patients: does the CARMENA trial lead to a paradigm shift?Bull Cancer. 2018 Dec;105 Suppl 3:S229-S234. doi: 10.1016/S0007-4551(18)30377-1. Bull Cancer. 2018. PMID: 30595151
Cited by
-
SIRPG promotes lung squamous cell carcinoma pathogenesis via M1 macrophages: a multi-omics study integrating data and Mendelian randomization.Front Oncol. 2024 Jun 4;14:1392417. doi: 10.3389/fonc.2024.1392417. eCollection 2024. Front Oncol. 2024. PMID: 38894865 Free PMC article.
-
Insight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer.Cancers (Basel). 2023 Feb 28;15(5):1532. doi: 10.3390/cancers15051532. Cancers (Basel). 2023. PMID: 36900322 Free PMC article. Review.
-
The efficacy and safety of a novel PD-1/CTLA-4 bispecific antibody cadonilimab (AK104) in advanced non-small cell lung cancer: A multicenter retrospective observational study.Thorac Cancer. 2024 Nov;15(32):2327-2338. doi: 10.1111/1759-7714.15455. Epub 2024 Oct 11. Thorac Cancer. 2024. PMID: 39390972 Free PMC article.
-
Pathologic response as an early endpoint for survival following neoadjuvant androgen deprivation therapy plus abiraterone acetate for metastatic prostate cancer.Eur J Med Res. 2025 Apr 4;30(1):238. doi: 10.1186/s40001-025-02521-7. Eur J Med Res. 2025. PMID: 40186317 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
